نتایج جستجو برای: validated
تعداد نتایج: 118567 فیلتر نتایج به سال:
Many complex systems present an intrinsic bipartite structure where elements of one set link to elements of the second set. In these complex systems, such as the system of actors and movies, elements of one set are qualitatively different than elements of the other set. The properties of these complex systems are typically investigated by constructing and analyzing a projected network on one of...
Dianne L. Chambless, William C. Sanderson, Varda Shoham, Suzanne Bennett Johnson, Kenneth S. Pope, Paul Crits-Christoph, Mary Baker, Benjamin Johnson, Sheila R. Woody, Stanley Sue, Larry Beutler, David A. Williams, and Susan McCurry Corresponding author: Dianne L. Chambless, Dept. of Psychology, UNC-CH, Chapel Hill, NC 27599-3270. Telephone: 919-962-3989, FAX: 919-962-2537, E-mail: chambles@ema...
BY DEFINITION, a validated supercentenarian is a properly documented centenarian who has lived to be at least the age of 110 years. The tables reproduced below and various other tables of supercentenarians are regularly updated by Dr. Stephen Coles, one of the members of our Editorial Board, along with other members of the Los Angeles Gerontology Research Group (GRG). For further details, pleas...
A set of validated numerical integration methods based on explicit and implicit Runge-Kutta schemes is presented to solve, in a guaranteed way, initial value problems of ordinary differential equations. Runge-Kutta methods are well-known to have strong stability properties, which make them appealing to be the basis of validated numerical integration methods. A new approach to bound the local tr...
Phytohormones are long time known as important components of signaling cascades in plant development and plant responses to various abiotic and biotic challenges. Quantifications of phytohormone levels in plants are typically carried out using GC or LC-MS/MS systems, due to their high sensitivity, specificity, and the fact that not much sample preparation is needed. However, mass spectrometer-b...
PURPOSE Many anticancer therapies benefit only a subset of treated patients and may be overlooked by the traditional broad eligibility approach to design phase III clinical trials. New biotechnologies such as microarrays can be used to identify the patients that are most likely to benefit from anticancer therapies. However, due to the high-dimensional nature of the genomic data, developing a re...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید